Accuray Inc Reports a Net Loss of $9.28 Million for the Year Ended June 30, 2023
Annual Revenue Reaches $447.61 Million
ACCURAY INC [ARAY], a leading provider of radiation oncology solutions, has announced its financial results for the year ended June 30, 2023. The company reported a net loss of $9.28 million, compared to a net loss of $5.35 million in the previous year. Despite the loss, Accuray Inc achieved strong annual revenue of $447.61 million, reflecting a growth of 4% compared to the previous year.
Financial Performance
Accuray Inc's financial performance for the year remained steady, with operating income of $2.38 million. This is a decrease from the operating income of $8.15 million in the previous year. The decrease in operating income can be attributed to higher operating expenses, including research and development, selling and marketing, and general and administrative expenses.